Back To Search Results

Microsporidial Keratitis

Editor: Koushik Tripathy Updated: 3/7/2024 8:51:36 PM

Introduction

Keratitis, an inflammation of the cornea accompanied by the infiltration of inflammatory cells, is predominantly caused by trauma or infection. Microspordial keratitis, originally termed "corneal nosematosis," is a rare form caused by microsporidia.[1][2] Microsporidia are obligate intracellular spore-forming parasites, similar to fungi that infect insects, birds, fish, and mammals.[1] Of the many known genera, only 7 infect humans.[3]

Microsporidia primarily causes gastrointestinal infections, but ocular, cerebral, and musculoskeletal infections are possible. Risk factors for ocular infection include contact lens use, trauma, eye surgery, topical corticosteroids, and exposure to soil, mud, dirty water, or thermal springs. Ocular infection with microsporidia typically manifests as keratoconjunctivitis or deep stromal keratitis.

The first documented case of microspordial keratitis was reported in a child from Sri Lanka in 1973. During the AIDS epidemic in the 1990s, the number of cases of microsporidial keratoconjunctivitis in patients who were immunocompromised increased. Since the early 2000s, cases of microspordial keratoconjunctivitis in immunocompetent hosts have continued to rise. Cases of microsporidial stromal keratitis occur primarily in immunocompetent hosts. Most cases of ocular microsporidia infection originate in Asia. Diagnosis and treatment of the disease may be challenging due to a lack of awareness among healthcare professionals regarding its diverse clinical presentations and disease progression. 

The robust spores persist in the environment for several months, remaining infectious. Human contraction of the infection can occur through ingestion, inhalation, or intimate activities. Although the method by which microsporidia infiltrate the human cornea remains elusive, the prevailing theory suggests contact with contaminated water or direct trauma.[1] Researchers have documented cases following exposure to floodwaters.

Diagnosis of microsporidial keratitis typically involves optical microscopy and polymerase chain reaction (PCR) to confirm the presence of the parasite. Treatment with topical medications yields varied success rates, and in some cases, surgical intervention may be necessary. Microsporidial keratitis can result in a significant decrease in visual acuity and a perforated corneal ulcer. With the exact transmission mechanism being unknown, prevention of infection is complicated. Healthcare professionals should consider microsporidial keratitis when evaluating patients with keratitis of unknown origin, particularly those who have traveled or returned from Asia, especially during the rainy season.

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

Microsporidia are spore-forming intracellular organisms found nearly everywhere in nature. Traditionally classified under the kingdom Protista, they have been recently reclassified as fungi based on molecular studies.[4][5] With over 1700 species, the most common species involved in human infection are Enterocytozoon bieneusi and the Encephalitozoon species, primarily Encephalitozoon intestinalisMicrosporidium and Vittaforma corneae are the most common causes of microspordial stromal keratitis, and Encephalitozoon species are the most common cause of microspordial keratoconjunctivitis.[4]  

In addition to primitive genomes and ribosomes similar to protozoa, the absence of mitochondria, centrioles, and peroxisomes gives microsporidia its prokaryotic features. However, the presence of mitochondrial hsp70, mitosome, and alpha-beta tubulin has resulted in their reclassification to fungi.[6][7]

Microsporidia are opportunistic waterborne pathogens commonly transmitted through contaminated water, like lakes, swamps, swimming pools, or spring water.[8][9][10] Among humans, microsporidia affects the gastrointestinal tract, brain, eyes, muscles, bones, and lungs.[11] While microspordial keratoconjunctivitis and microspordial stromal keratitis are the most prevalent ocular presentations, microsporidia also cause scleritis and endophthalmitis.[5][12][13] Historically, individuals who develop microsporidial keratoconjunctivitis were immunocompromised, often associated with HIV infection.[14][15] However, recent literature indicates that even immunocompetent patients can experience keratoconjunctivitis.[16][17][18] Conversely, deep stromal keratitis is primarily observed among immunocompetent individuals. 

Epidemiology

Endemic to Southeast and South Asian countries, ocular microsporidiosis is an infrequent but noteworthy contributor to infectious keratitis, with a prevalence of 0.4% observed in certain regions.[19] Specifically, Thailand, Taiwan, Singapore, and India are identified as endemic areas for microsporidial keratitis, marked by an upsurge in reported cases.[19] Adopting advanced diagnostic techniques, including various staining methods and PCR, has facilitated more accurate and timely diagnoses of this condition.

A notable study reveals that nearly 20% of all clinically diagnosed cases of infective keratitis in these regions are attributed to microsporidia, with incidences peaking during the rainy season. Moreover, a study conducted in South India involving over 10,000 patients with conjunctivitis unveils a significant proportion presenting with microsporidial keratoconjunctivitis among those who underwent corneal scraping. The underreporting of ocular microsporidia infection is likely due to the self-limited nature of microsporidial keratoconjunctivitis and the lack of comprehensive evaluations in patients with conjunctivitis. Clinicians often rely on clinical diagnosis due to these factors.[19] Large-scale epidemiological studies are imperative to clarify further endemic zones, geographical variation, and the mode of disease transmission.[19][20][21] 

Pathophysiology

Microsporidium is an obligate intracellular spore providing enhanced dispersion and protection against adverse environmental conditions. Its cell wall comprises a double envelope, with the outer portion containing glycoproteins and the inner part primarily chitin. The cytoplasm and nuclei form the infectious portion, known as sporoplasm. Changes in pH, exposure to certain cations, or low-dose ultraviolet radiation stimulate the polar filament to inject sporoplasm into the host.[22] Interestingly, spore intake occurs in cell cultures without releasing these polar tubules.

Factors inhibiting germination are magnesium chloride, ammonium chloride, minimal salt levels, sodium fluoride, ultraviolet exposure, temperatures >40 °C, and agents like itraconazole. Once inside the host cell, new spores form and infect neighboring cells. The symptoms and severity of microsporidiosis vary depending on the infecting species and the host's immune response, with severe cases often observed in significantly immunocompromised patients, particularly those with HIV.

Direct inoculation from contaminated water is the most likely cause of infection. Risk factors for acquiring microsporidial keratitis include contact lens usage, particularly inadequate hand hygiene or lens care practices, topical corticosteroid application, insect bites, ocular surgeries, and contact with domestic animals.[10] Immunosuppression remains a notable risk factor. The increased incidence during the rainy season suggests water contaminated with microsporidia or an increased insect population may contribute to transmission. The presence of risk factors among affected individuals varies widely, ranging from as low as 22.2% to as high as 100%.

The exact transmission route of ocular microsporidiosis remains unclear. While fecal-oral transmission is implicated in intestinal microsporidiosis, the viability of microsporidia spores against variable temperatures suggests alternative routes.[23] Certain pathogenic strains have been identified in both surface and groundwater, suggesting that unsanitary water sources, combined with subpar sanitary infrastructures, can be the nidus of infection.

Ocular trauma is another possible transmission route, as it can directly introduce these organisms into the corneal epithelium upon contact with soil or water-containing spores. The United States Environmental Protection Agency (EPA) recognizes microsporidia as a potential microbial waterborne contaminant.[24]

While the literature lacks a precise threshold, a CD4+ T-lymphocyte count below 100 cells/mm3 is commonly associated with increased susceptibility to microsporidial infection.[25][26]  Earlier research indicates a correlation between diminished CD4+ counts, often observed in individuals with AIDS, and the development of microsporidial keratoconjunctivitis. However, findings from Loh et al challenge this immunity-based theory, revealing a significant percentage of cases with normal CD4+ and CD8+ T-lymphocyte counts and negative serology.[27]  

Histopathology

The morphological identification of organisms on corneal tissue scrapings plays a crucial role in diagnosing microsporidial keratitis. The most helpful stain combines 10% potassium hydroxide (KOH) with 0.1% calcofluor white (KOH+CFW). A recent report by Mittal et al demonstrates that microsporidia spores are strongly acidic and heat fast. They stain strongly and most discretely when stained with the conventional Ziehl-Neelsen staining method using 20% sulphuric acid. A Gram stain reveals intraepithelial, gram-positive, oval-shaped spores on transmission electron microscopy. Characteristic periodic acid–Schiff-positive granules are identifiable at one end of mature microsporidia spores. However, the Giemsa stain is not considered useful due to its low sensitivity in detecting microsporidia. 

Corneal button specimens in patients infected with Vittaforma corneae reveal oval-shaped spores measuring 3.5 to 5 µm and 11 to 13 coils in the polar tubule.[28] The spores of the Encephalitozoon species are 2 to 3 µm and contain 4 to 7 coils in the polar tubule.[28] Most notable with the Encephalitozoon species is the presence of a parasitophorous vacuole, a protective bubble made of plasma membrane surrounding microsporidia in the host. The spores are the only form that can survive outside the host cell. Histopathology reveals varying degrees of inflammation with a near absence of inflammatory cells in patients who are immunosuppressed.[29] Organisms commonly confused morphologically with microsporidia are Toxoplasma gondiiLeishmania spp., Histoplasma capsulatum, and Cryptosporidia spp.[30]

History and Physical

Examination for microsporidial keratitis involves a thorough evaluation of the patient's ocular symptoms, medical history, and risk factors for infection. Clinical examination typically includes a detailed assessment of visual acuity and slit-lamp biomicroscopy to inspect the cornea for characteristic findings such as epithelial lesions, stromal infiltrates, and conjunctival inflammation. Additionally, associated symptoms such as redness, tearing, photophobia, and foreign body sensation are noted.

Microsporidial Keratoconjunctivitis

Infection caused by Encephalitozoon species typically remains localized to the epithelial cells of the cornea and conjunctiva. In patients with microsporidial keratoconjunctivitis, symptoms usually appear 1 to 2 weeks after exposure. Patients often report exposure to contaminated water or trauma, mainly in the rainy season. Additionally, a history of exposure to pool water, natural springs, contaminated soil, topical steroid use, insect bites, contact with domestic animals, or participation in water sports may be present. 

Common complaints include redness, decreased visual acuity, tearing, eyelid swelling, eye pain, and a foreign body sensation. Initially, symptoms are typically unilateral but can progress to both eyes.[8] Bilateral involvement is more likely in patients with compromised immune systems, occurring in up to 32% of cases in healthy individuals. Both eyes may be affected simultaneously, or symptoms may develop in 1 eye first, followed by the other within 1 week to 3 months.

Clinical examination features include the following:[31][32]

  • Multiple fine to coarse punctate, raised epithelial corneal lesions with a stuck-on appearance
  • Lesions stain variably with fluorescein
  • Lesions localize peripherally, paracentral, or diffusely
  • Significant conjunctival congestion
  • Typically not purulent
  • Potential anterior chamber inflammation and keratic precipitates

Some cases present with multiple subepithelial punctate infiltrates, making microsporidial keratoconjunctivitis indistinguishable from adenoviral keratoconjunctivitis. Reports exist of a pseudomembrane forming on the conjunctiva.

The disease can be graded from grade 1 to 4 depending on the presenting features:

  • Grade 1: The lesions are greyish-white, <10 in number, and distributed mainly in the peripheral cornea.
  • Grade 2: The lesions are central, 10 to 20 in number, elevated epithelial lesions.
  • Grade 3: The lesions are 21 to 40 in number.
  • Grade 4: The lesions are primarily peripheral and have subepithelial infiltrates.

Disease progression can lead to outcomes like superficial punctate keratitis, which may eventually cause scarring beneath the epithelium. Atypical presentations of microsporidial keratoconjunctivitis can manifest as unique corneal patterns or conditions that mimic other eye diseases, such as Thygeson superficial punctate keratitis. [27]

Microsporidial Stromal Keratitis 

Microsporidial stromal keratitis occurs primarily in immunocompetent individuals and is commonly associated with infections caused by Vittaforma corneae and Microsporidium. This form of infection typically targets the corneal stroma, including the keratocytes. The clinical history and presentation are similar to microsporidial keratoconjunctivitis, but affected patients may have a history of multiple episodes of remission and recurrence.

On average, patients experience symptoms 1 month to 2 years before presentation.[33][34] Clinical manifestations include multifocal, mid to deep stromal infiltrates with the overlying epithelium remaining intact. The stromal infiltrates are nonspecific and associated with edema with or without deep stromal vascularization. The infiltrate can be ulcerative at times.[35]

In cases where patients present with a history of chronic culture-negative stromal keratitis, clinicians should consider including microsporidial stromal keratitis in the differential diagnosis.[34] This form of keratitis can often be overlooked due to its atypical presentation and the challenges associated with its diagnosis.

Evaluation

Scrapings or biopsies of the conjunctiva or cornea typically serve as the primary diagnostic method for confirming microsporidial keratitis. These samples are subjected to various laboratory tests to facilitate the visualization of microsporidia spores.

Transmission Electron Microscopy

Historically, transmission electron microscopy (TEM) played a crucial role in elucidating the classification and comprehension of human microsporidia infections, including those impacting the eye. The distinctive polar tubule, observed through TEM, plays a vital role in identifying and classifying the organism within the Microspora phylum. Despite TEM remaining the gold standard for confirming and identifying microsporidia species, its complex procedure and limited accessibility restrict its practical utility in clinical diagnostics.[36]

Smear Diagnosis

Optical microscopy is a primary method for diagnosing microsporidiosis, as microsporidia are obligate intracellular organisms that cannot be cultured in routine media and require cell cultures for growth. Due to the challenges in consistently culturing microsporidia, direct smear findings become essential. Corneal abnormalities in patients with microsporidial keratoconjunctivitis appear raised and superficial. Clinicians typically scrape off these lesions with a 15-scalpel blade after applying topical anesthetic, and the samples undergo staining to identify microsporidia spores.

Smears initially used for Gram staining can be reused by decolorizing and reapplying a Ziehl-Neelsen stain, thus eliminating the necessity for additional scrapings.[37] Several staining methods are available for verifying the diagnosis of microsporidial keratoconjunctivitis from corneal and conjunctival samples. The combined 10% potassium hydroxide (KOH) with 0.1% calcofluor white (KOH+CFW) staining is the most preferred due to its superior detection rate, closely followed by the modified Ziehl-Neelsen stain, particularly when a fluorescence microscope is not available. The Gram stain follows, with Giemsa staining being the least preferred.

Some researchers have successfully used the modified trichrome staining method when diagnosing microsporidial keratoconjunctivitis.[38] Identification by staining does not allow for identification of the specific species involved. PCR is more commonly used for species-specific identification than electron microscopy.

Due to the presence of deep stromal infiltrates, diagnosing microsporidial stromal keratitis poses greater challenges. Corneal scrapings may not provide sufficient diagnostic information in this condition. A corneal biopsy or therapeutic penetrating keratoplasty in chronic culture-negative keratitis is a valid option to reach the diagnosis. The biopsy or excised corneal button is subjected to histopathological evaluation for a tissue diagnosis. 

Molecular Techniques in Diagnosis

PCR is a powerful tool for diagnosing microsporidial infections and determining the species involved. This molecular technique targets pathogen DNA by binding to a specifically designed set of primers and amplifying it repeatedly in the presence of free nucleotides by a thermostable polymerase enzyme. Utilizing known sequenced pan-microsporidia primers, PCR amplifies a fragment of 16S rRNA, offering a sensitivity of 83% and specificity of 98%.[39] 

Nucleic acids extracted from corneal scrapings or biopsies typically undergo a pan-microsporidian PCR followed by DNA sequencing and a Basic Local Alignment Search Tool (BLAST) search for species-specific identification. Recently, a duplex PCR method has emerged, incorporating pan-microsporidian primers and species-specific ones for Vittaforma corneae.[40] Despite the availability of specific primers for ocular microsporidia species since 1994, they have not gained significant traction in clinical microbiology. Compared to earlier methods, a notable absence of commercial kits specifically designed for diagnosing ocular microsporidiosis exists. 

Introduced in 1996, PCR combined with Southern analysis has successfully distinguished Encephalitozoon species in urine samples. However, its widespread adoption for ocular infections has been limited thus far. Nonetheless, PCR remains a valuable tool for various microsporidia infections across diverse clinical specimens. For example, a 2004 study by Conners et al detailed a PCR method using specific rRNA primers, followed by sequencing to identify microsporidia in corneal samples.

Other studies indicate the utility of real-time PCR assays and multiplex PCR in different contexts, showing potential for broad applications, including the diagnosis of microsporidial keratoconjunctivitis. A newly reported oligonucleotide microarray also seems promising, showcasing the ability to detect multiple species. Its efficacy in ocular sample diagnostics is yet to be determined.[41]

Cell Cultivation Techniques

Due to their intracellular nature, microsporidia can only propagate in cell culture systems. During the early 1990s, researchers successfully adapted 3 microsporidia isolates, specifically Encephalitozoon hellem, from corneal tissue and conjunctival samples of patients with AIDS to Madin-Darby Canine kidney epithelial (MDCK) cells.

Additionally, various other cell types were evaluated for cultivating microsporidia, such as E6, HLF, MRC-5, RK-13, HeLa, Vero, SIRC, and fetal bovine lung fibroblasts. The Vero cell line proved the most effective when comparing the Vero, HeLa, and SIRC cell lines for growing 4 distinct microsporidia species.[42] Despite these advancements, the method of nurturing these organisms in cell lines has not been streamlined for the routine diagnosis of microsporidial keratoconjunctivitis.[42]

Antigen Detection Techniques

In clinical microbiology, antigen detection using various specimens is a common way to identify numerous infectious conditions. This method frequently involves the use of either monoclonal or polyclonal antibodies. Specific antibodies, especially those targeting the spore wall or polar tubule, are available for multiple microsporidia species.[43] Research from the early 20th century indicates the effective application of immunofluorescent antibody techniques to identify ocular microsporidia using species-specific antisera.[40] 

Many researchers feel antigen detection techniques are less sensitive than PCR and, if used, should be used as a supplement to conventional histological methods. Indirect immunofluorescence assay is neither widely available on the market nor regularly used in diagnosing ocular microsporidiosis. In addition, testing for specific antibodies against microsporidia in blood for diagnostic purposes in cases of ocular microsporidiosis is not endorsed and remains inaccessible.[43]

Imaging Techniques

Anterior segment optical coherence tomography (AS-OCT) offers a contact-free, high-definition method to visualize cross-sections of the cornea. A study by Thanathanee et al reveals the following changes in patients with microsporidia keratoconjunctivitis:

  • Hyperreflective dots are limited to the epithelial layers of the cornea
  • No extension into the stromal layer 
  • Hyperreflective dots are slightly raised above the epithelial surface in most cases

These features distinguish microsporidia lesions from the nummular scars caused by adenovirus, which present as more prominent subepithelial anomalies, manifesting milder reflectivity and a smoother epithelial surface. Coupled with microbiological analyses, AS-OCT may offer diagnostic clarity and a means to track treatment progress. Further studies are necessary.[44]

In Vivo Confocal Microscopy 

In vivo confocal microscopy (IVCM) is a ground-breaking tool for diagnosing ocular infections. Using IVCM, the lesions of microsporidial keratoconjunctivitis appear as epithelial clusters accompanied by bright, pinpoint-shaped spores. Clinicians can distinguish from adenovirus keratoconjunctivitis based on the presence of a bright basal epithelium, dendritic cells, and active keratocytes in the superficial stroma at the center of the cornea. Additionally, IVCM can potentially assess treatment efficacy and evaluate for deeper stromal penetration. However, its adoption remains limited due to significant interobserver variability and high cost.[45]

Impression Cytology

Impression cytology involves the application of cellulose acetate filter paper to the eye's surface, allowing for the collection of superficial layers lining the ocular surface. Once collected, clinicians can do histological, immunohistological, or molecular analyses of the cells. This test offers a less invasive method and an alternative to corneal smear tests.

Limited documentation of its use exists in the literature, and its potential accuracy in terms of sensitivity and specificity requires further exploration. Through this technique, intracellular and extracellular spores, without inflammatory cells, have been identified, mirroring the findings of smear tests.[46]

Treatment / Management

No consensus exists regarding the management of microsporidial keratitis. The various treatment options are listed below:

Topical Therapy

Superficial infections are self-limited or treated medically. Deeper stromal involvement often requires corneal transplantation to eradicate the infection and improve vision.[47][35] Lubricants are effective for symptomatic relief. In a randomized controlled trial, lubricants are as effective as biguanides.[48] The frequency of lubricant application depends on the severity of patient symptoms, with more frequent dosing in more symptomatic patients. (A1)

Antimicrobial agents

Topical fumagillin and fluoroquinolones are important antimicrobials frequently used in treating microsporidial ocular infections.[4][49] Fluoroquinolones target the topoisomerase and DNA gyrase enzymes. Among fluoroquinolones, ciprofloxacin 0.3%, gatifloxacin 0.5%, moxifloxacin 0.5%, levofloxacin 0.5%, norfloxacin 0.3%, and ofloxacin 0.5% are effective against microsporidia dosed hourly with or without oral albendazole. However, the results are mainly anecdotal, from in vivo and in vitro studies, and not supported by randomized clinical trials.[16][27][16][49][50](B2)

On the other hand, fumagillin is a mycotoxin produced by Aspergillus and treats microsporidia by inhibiting RNA synthesis.[4] Fumagillin may also act by inhibiting the proteinase, type 2 methionine aminopeptidase. Some reports suggest a potential for relapse after treatment cessation. The concentration of bicyclohexyl ammonium fumagillin is 0.113 mg/ml.[16][51][52](B3)

Biguanides

Polyhexamethylene biguanide (PHMB) 0.02% and chlorhexidine gluconate 0.02% are 2 biguanides effective in treating microsporidial keratitis when combined with debridement.[17] Both PHMB and chlorhexidine are disinfectant antiseptics requiring reconstitution to 0.02% as they are not commercially available in the given concentration. Dosing is as frequent as every 30 to 60 minutes.[48](A1)

Diamidines

Sparse reports have highlighted compounds such as propamidine isethionate and hexamidine isethionate 0.1% as part of combination treatments. Currently, in vitro susceptibility testing for these cationic antiseptics does not exist.[53](B3)

Immune modulation and steroids

Patients with persistent or recurrent disease warrant a short course of topical steroids or steroid-sparing agents like tacrolimus 0.3% and cyclosporine 0.5%.[54][55][56] Tacrolimus and cyclosporine modulate and suppress corneal inflammatory responses. Apart from this, patients who develop endotheliitis, limbitis, and anterior chamber reactions warrant topical steroids.[19][21][19][27] Some studies suggest that the early application of topical steroids can prevent complications when dealing with specific types of keratitis. However, unlike adenovirus, studies have not conclusively shown steroids' impact on microsporidia multiplication.(B2)

Antifungal agents

Microsporidia are related to fungi. Azoles treat fungi by inhibiting ergosterol synthesis in the plasma membrane of fungi. Research published by Agatha and others involving 550 patients reveals that fluconazole 0.3%, dosed 4 times daily until symptom resolution, effectively achieves over 95% visual recovery.[21][57]  

Oral Therapy

Antifungals

Itraconazole, an oral antifungal medication, has been administered to treat specific infections without any relapses. However, its definitive efficacy is still under scrutiny.[58] Oral Itraconazole 200 mg/d is effective for disseminated diseases; however, the effectiveness of an oral antifungal in treating microsporidial keratitis has not been established.[59](B3)

Antiprotozoal and antihelminthic medications

Albendazole is an antiprotozoal effective in treating microsporidial keratoconjunctivitis.[60] It exerts its action by inhibiting microtubules, thus impeding cell division. Albendazole is most effective against Encephalitozoon species, with a recommended dose of 400 mg twice daily.[49] (B3)

Corneal Swabbing and Surgical Management

In microsporidial keratoconjunctivitis, the debridement of the corneal epithelium serves dual purposes: collecting samples for microbiological evaluation and reducing the microbial load. This procedure typically involves using a 15-blade or 26-gauge needle, and the affected area normally heals without scarring.[17] Debridement can be utilized alone or with antimicrobial and lubricating agents. However, debridement is not superior to conservative management and increases the risk of superimposed infection. Therefore, it is advisable to reserve debridement for severe cases.[61] (A1)

Repeated corneal swabbing using cotton swabs is another effective, relatively less invasive procedure proposed by Fan and colleagues. This method involves repetitive swabbing of the cornea using cotton swabs, which is less intrusive, causes minimal discomfort, is generally well-received by patients. Moreover, results are typically evident within a week of the procedure.[19] (B2)

The outlook for stromal disease is less optimistic. While some case reports describe successful medical treatment, the efficacy varies. Medications used alone or in combination include topical polyhexamethylene biguanide, chlorhexidine, and voriconazole with or without oral itraconazole or albendazole. However, one study revealed that less than half of the patients responded to medical therapy consisting of topical polyhexamethylene biguanide and chlorhexidine, with or without oral albendazole. Ultimately, 25 of the 34 patients required keratoplasty. Therapeutic penetrating keratoplasty often emerges as the only viable option for patients with corneal stromal involvement.[34][62](B3)

Differential Diagnosis

The differential diagnoses for microsporidial keratoconjunctivitis include:[55]

  • Adenoviral keratoconjunctivitis
  • Thygeson superficial punctate keratitis
  • Dry eye disease
  • Filamentary keratitis
  • Vesicular stage of herpes simplex virus epithelial keratitis
  • Acanthamoeba keratitis
  • Atypical mycobacterial keratitis
  • Viral keratoconjunctivitis 
  • Bacterial conjunctivitis

Thygeson superficial punctate keratitis typically presents bilaterally, featuring coarse raised epithelial lesions predominantly located centrally. This condition responds favorably to treatment with topical steroids.

The differential diagnoses for microsporidial stromal keratitis include:

  • Herpetic stromal keratitis
  • Fungal corneal ulcer
  • Bacterial corneal ulcer

Prognosis

Microsporidial stromal keratitis often follows a pattern of remission and recurrence until surgically removed via penetrating keratoplasty. Conversely, microsporidial keratoconjunctivitis typically resolves without any long-term sequelae or residual effects. In a study involving 332 patients treated for microsporidial keratoconjunctivitis, 49 returned for reevaluation at 6 weeks. Among the returning patients, 16 individuals (4.8%) returned for symptoms of microsporidial keratoconjunctivitis, and the remaining patients had non-microsporidial keratoconjunctivitis eye complaints like refractive error and dacrocystitis. The 3 manifestations of persistence were superficial punctate keratitis, sub-epithelial infiltrates, and uveitis. The 16 patients with symptoms of microsporidial keratoconjunctivitis underwent further treatment and achieved disease resolution. Some of them experienced recurrences at a later date. Visual acuity typically returns following successful treatment, with recovery rates ranging from 70% to 100%. However, unresolved subepithelial infiltrates may lead to worsening vision.[19]

Complications

Nummular scars can persist in cases of inadequately treated microsporidial keratoconjunctivitis. In cases of stromal keratitis, corneal scars and edema usually increase with each recurring episode of inflammation.[55] Increased intraocular pressure due to topical corticosteroid use is an additional medication-related complication. Other potential sequelae are limbitis, endotheliitis, and keratic precipitates.[55] These can be treated with topical steroids.[54]

Postoperative and Rehabilitation Care

Postoperative and rehabilitation care following microsporidial keratitis treatment is crucial for optimal recovery and visual outcomes. This comprehensive care regimen typically includes diligent monitoring of the surgical site, regular administration of prescribed medications, and adherence to specific postoperative instructions provided by the healthcare provider. Care consists of the following:

  • Medications
    • The first-line treatment for microsporidial keratitis is topical fumagillin, although its availability may be limited.
    • Alternative medications include oral albendazole, itraconazole, and topical propamidine isethionate.
    • Avoid corticosteroids or use them cautiously, as they can exacerbate the infection. When used, administer along with appropriate antifungal therapy to control inflammation.[55]
  • Regular monitoring
    • Regular repeat evaluations are crucial to monitor the healing process, check for any complications, and assess the effectiveness of the treatment.
    • Slit-lamp examinations aid in monitoring the resolution of the keratitis.[63]
  • Visual rehabilitation
    • Once the infection has cleared, some patients may have residual corneal scarring, which can affect vision.
    • A corrective spectacle prescription or contact lenses may be necessary
    • For severe scarring, corneal transplantation or keratoplasty may restore vision.[23]
  • Protective measures
    • Post-infection, sunglasses can help in reducing light sensitivity 
    • Using protective eyewear in environments that put individuals at risk can prevent future episodes, especially in agricultural settings or where the risk of trauma is high.[63]
  • Patient education
    • Educate patients regarding the importance of completing the medication regimen even if symptoms improve.
    • Inform patients about the potential risk factors and preventive measures to prevent microsporidial keratitis.[63]
  • Physical therapy
    • If a patient has been incapacitated or bedridden due to severe infection or another concurrent medical condition, physical rehabilitation may be necessary to regain muscle strength and function.[63]
  • Counseling and mental health
    • Dealing with visual impairment or a significant ocular condition can be stressful. Providing counseling or mental health resources can be beneficial for some patients.[63]
  • Nutritional support
    • Adequate nutrition is essential for healing. Ensure the patient maintains a balanced diet to support the healing process.[63]

Consultations

Consultations for treatment of microsporidial keratitis include the following:

  • Ophthalmologist: An eye specialist should be consulted to diagnose, monitor, and treat the condition.
  • Infectious disease specialist: For patients who are immunocompromised or have a suspicion of systemic involvement.
  • Cornea specialist: If the keratitis does not resolve with standard treatments, surgical intervention, like a corneal transplantation, becomes necessary.

Deterrence and Patient Education

Microsporidia are a rare and commonly misdiagnosed cause of corneal infection. Ocular infection typically presents as keratoconjunctivitis or stromal keratitis. Patients must understand how to reduce their risk of infection. The following is a list of recommendations to help reduce the risk of infection:

  • Avoid contaminated water sources
  • Use protective eyewear while swimming or participating in water sports
  • Frequently wash hands with soap and water, especially after handling soil, gardening, or coming in contact with animals
  • Avoid touching the eyes with dirty hands.[64] 

Patients with contact lenses should:

  • Always wash their hands before handling lenses
  • Use sterile lens solutions for cleaning and storing contact lenses
  • Clean the lens storage case daily and replace it regularly
  • Do not sleep in contact lenses unless they are approved for overnight use [65]

Patients should understand that the symptoms of microsporidial keratitis are redness, pain, tearing, photophobia, blurred vision, and a foreign body sensation. Various treatment options are available, from topical and oral medications to surgical interventions. The majority of patients with microsporidial keratoconjunctivitis will have self-limited disease, and treatment options are removal of the microbes with a cotton swab and symptomatic treatment with lubricants, topical antimicrobials, and oral antifungals and anthelmintic medications.

The stromal disease has a less optimistic prognosis, and corneal transplantation may be necessary. Patients must understand the importance of completing the entire course of treatment, returning at regularly scheduled intervals, and calling with any evidence of recurrence.[3]

Encourage patients to share information about microsporidial keratitis with family and friends, especially those at risk. Proper deterrence strategies and patient education minimize the risk of infection, and outcomes can be improved. Regular consultation with healthcare professionals is essential for early detection and effective management.[66]

Pearls and Other Issues

Key facts to keep in mind about microsporidial keratitis include the following:

  • Clinical presentation: Patients typically present with symptoms of a painful red eye, photophobia, tearing, a foreign body sensation, and decreased visual acuity. The clinical picture may resemble viral or fungal keratitis.
  • Slit-lamp examination: On slit-lamp examination, microsporidial stromal keratitis appears as diffuse multifocal mid- to deep stromal infiltrates with mild to moderate conjunctival injection, stromal edema, and endothelial exudates. Microsporidial keratoconjunctivitis has variable presentations, which likely signify different disease stages. Mild to severe nonpurulent conjunctivitis and grayish-white, coarse, multifocal, raised epithelial lesions resolve after 1 week. Next, central epithelial lesions and superficial punctate keratopathy develop. After 2 to 4 weeks, subepithelial infiltrates or a haze may form. 
  • Laboratory diagnosis: The diagnosis can be confirmed by scraping the affected corneal epithelium and examining the sample under a microscope. Specimens stained with KOH+CFW, Ziehl-Neelsen, or Graham stains are best for visualizing microsporidia. Transmission electron microscopy can provide a definitive diagnosis but may not be readily available.
  • PCR testing: PCR assays can be beneficial in diagnosing microsporidial infections by making a diagnosis and identifying the specific species involved. 
  • Antifungal medications: Microsporidia are closely related to fungi and respond to some antifungal medications. Topical fumagillin is effective but only sometimes readily available. Alternatives are oral itraconazole or albendazole.
  • Debridement: Superficial debridement of the infected epithelium can help reduce the parasitic load and enhance the penetration of topical medications.
  • Avoid steroids: The use of corticosteroids may exacerbate the infection. Consider using tacrolimus or cyclosporin alone.
  • Missed diagnosis: Diagnosis can be challenging due to the rarity of the disease and the overlap of clinical features with more common forms of keratitis.
  • Lack of specific medication: A lack of readily available and specific treatment guidelines for microsporidial keratitis can make management challenging.
  • Recurrence: Despite successful treatment, recurrence can happen, and proper long-term care is necessary.

Enhancing Healthcare Team Outcomes

Patients experiencing ocular microsporidia infections face the risk of recurrence, vision loss, and potential corneal transplantation. Given the self-limiting nature of microsporidial keratoconjunctivitis and the absence of consensus on medical management for microsporidial keratoconjunctivitis and microsporidial stromal keratitis, an interdisciplinary approach becomes crucial for optimal patient care.

Early identification and effective management of microsporidial stromal keratitis are essential to minimize morbidity. Primary care, ophthalmology, and infectious disease clinicians must possess crucial clinical skills and knowledge for diagnosing and managing ocular microsporidia infections. Clinicians must recognize clinical presentations, understand potential overlaps with more common ocular conditions, and navigate the challenges of establishing accurate diagnoses.

Given the condition's rarity, the treatment approach must be strategic. Clinicians must use evidence-based therapies and rely on colleagues' expertise. Microsporidial ocular infections are uncommon. Each healthcare professional must contribute unique knowledge to the patient's care plan while engaging in effective interpersonal communication. Effective interprofessional communication allows for vital exchange of information and collaborative decision-making among the team members.

Patient education ensures proper long-term care, improved quality of life, and reduced morbidity. By embracing these principles of skill, strategy, responsibilities, and interprofessional communication, healthcare professionals can deliver the best possible patient care, ultimately improving patient outcomes and enhancing team performance in managing microsporidial ocular infections.

References


[1]

Vemuganti GK, Murthy SI, Das S. Update on pathologic diagnosis of corneal infections and inflammations. Middle East African journal of ophthalmology. 2011 Oct:18(4):277-84. doi: 10.4103/0974-9233.90128. Epub     [PubMed PMID: 22224015]


[2]

Didier ES, Stovall ME, Green LC, Brindley PJ, Sestak K, Didier PJ. Epidemiology of microsporidiosis: sources and modes of transmission. Veterinary parasitology. 2004 Dec 9:126(1-2):145-66     [PubMed PMID: 15567583]

Level 3 (low-level) evidence

[3]

Tung-Lien Quek D, Pan JC, Krishnan PU, Zhao PS, Teoh SC. Microsporidial keratoconjunctivitis in the tropics: a case series. The open ophthalmology journal. 2011:5():42-7. doi: 10.2174/1874364101105010042. Epub 2011 May 17     [PubMed PMID: 21643428]

Level 2 (mid-level) evidence

[4]

Weber R, Bryan RT, Schwartz DA, Owen RL. Human microsporidial infections. Clinical microbiology reviews. 1994 Oct:7(4):426-61     [PubMed PMID: 7834600]

Level 3 (low-level) evidence

[5]

Sharma S, Das S, Joseph J, Vemuganti GK, Murthy S. Microsporidial keratitis: need for increased awareness. Survey of ophthalmology. 2011 Jan-Feb:56(1):1-22. doi: 10.1016/j.survophthal.2010.03.006. Epub 2010 Nov 11     [PubMed PMID: 21071051]

Level 3 (low-level) evidence

[6]

Williams BA, Cali A, Takvorian PM, Keeling PJ. Distinct localization patterns of two putative mitochondrial proteins in the microsporidian Encephalitozoon cuniculi. The Journal of eukaryotic microbiology. 2008 Mar-Apr:55(2):131-3. doi: 10.1111/j.1550-7408.2008.00315.x. Epub     [PubMed PMID: 18318866]


[7]

Keeling P. Five questions about microsporidia. PLoS pathogens. 2009 Sep:5(9):e1000489. doi: 10.1371/journal.ppat.1000489. Epub 2009 Sep 25     [PubMed PMID: 19779558]


[8]

Huang AS, Cho JS, Bertram BA. Microsporidial Keratitis Related to Water Exposure: A Case Series. Cureus. 2021 Jun 19:13(6):e15760. doi: 10.7759/cureus.15760. Epub 2021 Jun 19     [PubMed PMID: 34164251]

Level 2 (mid-level) evidence

[9]

Chen JS, Hsu TK, Hsu BM, Chao SC, Huang TY, Ji DD, Yang PY, Huang IH. Swimming Pool-Associated Vittaforma-Like Microsporidia Linked to Microsporidial Keratoconjunctivitis Outbreak, Taiwan. Emerging infectious diseases. 2019 Nov:25(11):2100-2103. doi: 10.3201/eid2511.181483. Epub     [PubMed PMID: 31625849]


[10]

Wang WY, Chu HS, Lin PC, Lee TF, Kuo KT, Hsueh PR, Hu FR, Wang IJ. Outbreak of Microsporidial Keratoconjunctivitis Associated With Water Contamination in Swimming Pools in Taiwan. American journal of ophthalmology. 2018 Oct:194():101-109. doi: 10.1016/j.ajo.2018.07.019. Epub 2018 Jul 26     [PubMed PMID: 30055152]


[11]

Ashfaq A, White AC Jr. Microsporidiasis. Handbook of clinical neurology. 2013:114():183-91. doi: 10.1016/B978-0-444-53490-3.00012-1. Epub     [PubMed PMID: 23829908]

Level 3 (low-level) evidence

[12]

Mietz H, Franzen C, Hoppe T, Bartz-Schmidt KU. Microsporidia-induced sclerouveitis with retinal detachment. Archives of ophthalmology (Chicago, Ill. : 1960). 2002 Jun:120(6):864-5     [PubMed PMID: 12049604]

Level 3 (low-level) evidence

[13]

Yoken J, Forbes B, Maguire AM, Prenner JL, Carpentieri D. Microsporidial endophthalmitis in a patient with acute myelogenous leukemia. Retina (Philadelphia, Pa.). 2002 Feb:22(1):123-5     [PubMed PMID: 11884897]

Level 3 (low-level) evidence

[14]

Hollister WS, Canning EU, Colbourn NI, Curry A, Lacey CJ. Characterization of Encephalitozoon hellem (Microspora) isolated from the nasal mucosa of a patient with AIDS. Parasitology. 1993 Nov:107 ( Pt 4)():351-8     [PubMed PMID: 8278216]

Level 3 (low-level) evidence

[15]

Gritz DC, Holsclaw DS, Neger RE, Whitcher JP Jr, Margolis TP. Ocular and sinus microsporidial infection cured with systemic albendazole. American journal of ophthalmology. 1997 Aug:124(2):241-3     [PubMed PMID: 9262551]

Level 3 (low-level) evidence

[16]

Chan CM, Theng JT, Li L, Tan DT. Microsporidial keratoconjunctivitis in healthy individuals: a case series. Ophthalmology. 2003 Jul:110(7):1420-5     [PubMed PMID: 12867402]

Level 3 (low-level) evidence

[17]

Joseph J, Sridhar MS, Murthy S, Sharma S. Clinical and microbiological profile of microsporidial keratoconjunctivitis in southern India. Ophthalmology. 2006 Apr:113(4):531-7     [PubMed PMID: 16488011]

Level 2 (mid-level) evidence

[18]

Ashton N, Wirasinha PA. Encephalitozoonosis (nosematosis) of the cornea. The British journal of ophthalmology. 1973 Sep:57(9):669-74     [PubMed PMID: 4202149]


[19]

Fan NW, Wu CC, Chen TL, Yu WK, Chen CP, Lee SM, Lin PY. Microsporidial keratitis in patients with hot springs exposure. Journal of clinical microbiology. 2012 Feb:50(2):414-8. doi: 10.1128/JCM.05007-11. Epub 2011 Nov 23     [PubMed PMID: 22116156]

Level 2 (mid-level) evidence

[20]

Fan NW, Lin PY, Chen TL, Chen CP, Lee SM. Treatment of microsporidial keratoconjunctivitis with repeated corneal swabbing. American journal of ophthalmology. 2012 Dec:154(6):927-933.e1. doi: 10.1016/j.ajo.2012.06.002. Epub 2012 Sep 5     [PubMed PMID: 22959880]

Level 2 (mid-level) evidence

[21]

Agashe R, Radhakrishnan N, Pradhan S, Srinivasan M, Prajna VN, Lalitha P. Clinical and demographic study of microsporidial keratoconjunctivitis in South India: a 3-year study (2013-2015). The British journal of ophthalmology. 2017 Oct:101(10):1436-1439. doi: 10.1136/bjophthalmol-2016-309845. Epub 2017 Feb 22     [PubMed PMID: 28228409]


[22]

Xu Y, Weiss LM. The microsporidian polar tube: a highly specialised invasion organelle. International journal for parasitology. 2005 Aug:35(9):941-53     [PubMed PMID: 16005007]


[23]

Moshirfar M, Somani SN, Shmunes KM, Espandar L, Gokhale NS, Ronquillo YC, Hoopes PC. A Narrative Review of Microsporidial Infections of the Cornea. Ophthalmology and therapy. 2020 Jun:9(2):265-278. doi: 10.1007/s40123-020-00243-z. Epub 2020 Mar 10     [PubMed PMID: 32157613]

Level 3 (low-level) evidence

[24]

Hutin YJ, Sombardier MN, Liguory O, Sarfati C, Derouin F, Modaï J, Molina JM. Risk factors for intestinal microsporidiosis in patients with human immunodeficiency virus infection: a case-control study. The Journal of infectious diseases. 1998 Sep:178(3):904-7     [PubMed PMID: 9728570]

Level 3 (low-level) evidence

[25]

Bryan RT, Cali A, Owen RL, Spencer HC. Microsporidia: opportunistic pathogens in patients with AIDS. Progress in clinical parasitology. 1991:2():1-26     [PubMed PMID: 1893116]

Level 3 (low-level) evidence

[26]

Schwartz DA, Visvesvara GS, Diesenhouse MC, Weber R, Font RL, Wilson LA, Corrent G, Serdarevic ON, Rosberger DF, Keenen PC. Pathologic features and immunofluorescent antibody demonstration of ocular microsporidiosis (Encephalitozoon hellem) in seven patients with acquired immunodeficiency syndrome. American journal of ophthalmology. 1993 Mar 15:115(3):285-92     [PubMed PMID: 8095123]

Level 3 (low-level) evidence

[27]

Loh RS, Chan CM, Ti SE, Lim L, Chan KS, Tan DT. Emerging prevalence of microsporidial keratitis in Singapore: epidemiology, clinical features, and management. Ophthalmology. 2009 Dec:116(12):2348-53. doi: 10.1016/j.ophtha.2009.05.004. Epub 2009 Oct 7     [PubMed PMID: 19815287]

Level 2 (mid-level) evidence

[28]

Font RL, Samaha AN, Keener MJ, Chevez-Barrios P, Goosey JD. Corneal microsporidiosis. Report of case, including electron microscopic observations. Ophthalmology. 2000 Sep:107(9):1769-75     [PubMed PMID: 10964843]

Level 3 (low-level) evidence

[29]

Mittal R, Balne PK, Sahu S, Das S, Sharma S. Coexistence of herpes simplex virus infection in microsporidial stromal keratitis associated with granulomatous inflammation. Indian journal of ophthalmology. 2017 Apr:65(4):276-281. doi: 10.4103/ijo.IJO_761_15. Epub     [PubMed PMID: 28513490]


[30]

McCluskey PJ, Goonan PV, Marriott DJ, Field AS. Microsporidial keratoconjunctivitis in AIDS. Eye (London, England). 1993:7 ( Pt 1)():80-3     [PubMed PMID: 8325429]

Level 3 (low-level) evidence

[31]

Mokhtarzadeh M, Casey R, Glasgow BJ. Fluorescein punctate staining traced to superficial corneal epithelial cells by impression cytology and confocal microscopy. Investigative ophthalmology & visual science. 2011 Apr:52(5):2127-35. doi: 10.1167/iovs.10-6489. Epub 2011 Apr 5     [PubMed PMID: 21212176]

Level 3 (low-level) evidence

[32]

Agarwal P, Coc IR, Navon SE. Importance of clinical signs leading to the diagnosis in a case of microbiological smear negative ocular microsporidiosis. BMJ case reports. 2019 Feb 1:12(2):. doi: 10.1136/bcr-2018-228407. Epub 2019 Feb 1     [PubMed PMID: 30709889]

Level 3 (low-level) evidence

[33]

Pinnolis M, Egbert PR, Font RL, Winter FC. Nosematosis of the cornea. Case report, including electron microscopic studies. Archives of ophthalmology (Chicago, Ill. : 1960). 1981 Jun:99(6):1044-7     [PubMed PMID: 6786272]

Level 3 (low-level) evidence

[34]

Vemuganti GK, Garg P, Sharma S, Joseph J, Gopinathan U, Singh S. Is microsporidial keratitis an emerging cause of stromal keratitis? A case series study. BMC ophthalmology. 2005 Aug 17:5():19     [PubMed PMID: 16105181]

Level 3 (low-level) evidence

[35]

Garg P. Microsporidia infection of the cornea--a unique and challenging disease. Cornea. 2013 Nov:32 Suppl 1():S33-8. doi: 10.1097/ICO.0b013e3182a2c91f. Epub     [PubMed PMID: 24104931]


[36]

Didier PJ, Didier ES, Orenstein JM, Shadduck JA. Fine structure of a new human microsporidian, Encephalitozoon hellem, in culture. The Journal of protozoology. 1991 Sep-Oct:38(5):502-7     [PubMed PMID: 1920150]

Level 3 (low-level) evidence

[37]

Taju S, Tilahun Y, Ayalew M, Fikrie N, Schneider J, Kempen JH. Diagnosis and treatment of microsporidial keratoconjunctivitis: literature review and case series. Journal of ophthalmic inflammation and infection. 2011 Sep:1(3):105-10. doi: 10.1007/s12348-011-0025-y. Epub 2011 May 11     [PubMed PMID: 21559864]

Level 2 (mid-level) evidence

[38]

Das S, Sharma S, Sahu SK, Nayak SS, Kar S. Diagnosis, clinical features and treatment outcome of microsporidial keratoconjunctivitis. The British journal of ophthalmology. 2012 Jun:96(6):793-5. doi: 10.1136/bjophthalmol-2011-301227. Epub 2012 Mar 21     [PubMed PMID: 22437900]

Level 2 (mid-level) evidence

[39]

Joseph J, Sharma S, Murthy SI, Krishna PV, Garg P, Nutheti R, Kenneth J, Balasubramanian D. Microsporidial keratitis in India: 16S rRNA gene-based PCR assay for diagnosis and species identification of microsporidia in clinical samples. Investigative ophthalmology & visual science. 2006 Oct:47(10):4468-73     [PubMed PMID: 17003441]


[40]

Ghosh K, Weiss LM. Molecular diagnostic tests for microsporidia. Interdisciplinary perspectives on infectious diseases. 2009:2009():926521. doi: 10.1155/2009/926521. Epub 2009 Aug 2     [PubMed PMID: 19657457]

Level 3 (low-level) evidence

[41]

Conners MS, Gibler TS, Van Gelder RN. Diagnosis of microsporidia keratitis by polymerase chain reaction. Archives of ophthalmology (Chicago, Ill. : 1960). 2004 Feb:122(2):283-4     [PubMed PMID: 14769611]

Level 3 (low-level) evidence

[42]

Didier ES, Didier PJ, Friedberg DN, Stenson SM, Orenstein JM, Yee RW, Tio FO, Davis RM, Vossbrinck C, Millichamp N. Isolation and characterization of a new human microsporidian, Encephalitozoon hellem (n. sp.), from three AIDS patients with keratoconjunctivitis. The Journal of infectious diseases. 1991 Mar:163(3):617-21     [PubMed PMID: 1995733]

Level 3 (low-level) evidence

[43]

Mo L, Drancourt M. Monoclonal antibodies for specific detection of Encephalitozoon cuniculi. Clinical and diagnostic laboratory immunology. 2004 Nov:11(6):1060-3     [PubMed PMID: 15539506]

Level 3 (low-level) evidence

[44]

Thanathanee O, Laohapitakvorn S, Anutarapongpan O, Suwan-Apichon O, Bhoomibunchoo C. Anterior Segment Optical Coherence Tomography Images in Microsporidial Keratoconjunctivitis. Cornea. 2019 Aug:38(8):943-947. doi: 10.1097/ICO.0000000000001994. Epub     [PubMed PMID: 31276457]


[45]

Subaşı S, Yüksel N, Toprak M, Yılmaz Tuğan B. In Vivo Confocal Microscopy Analysis of the Corneal Layers in Adenoviral Epidemic Keratoconjunctivitis. Turkish journal of ophthalmology. 2018 Dec 27:48(6):276-280. doi: 10.4274/tjo.59251. Epub     [PubMed PMID: 30605932]


[46]

Singh R, Joseph A, Umapathy T, Tint NL, Dua HS. Impression cytology of the ocular surface. The British journal of ophthalmology. 2005 Dec:89(12):1655-9     [PubMed PMID: 16299150]


[47]

Sanjay S. Clinical trial of 0.02% polyhexamethylene biguanide versus placebo in the treatment of microsporidial keratoconjunctivitis. American journal of ophthalmology. 2011 Jan:151(1):183; author reply 183. doi: 10.1016/j.ajo.2010.08.029. Epub     [PubMed PMID: 21163375]

Level 3 (low-level) evidence

[48]

Das S, Sahu SK, Sharma S, Nayak SS, Kar S. Clinical trial of 0.02% polyhexamethylene biguanide versus placebo in the treatment of microsporidial keratoconjunctivitis. American journal of ophthalmology. 2010 Jul:150(1):110-115.e2. doi: 10.1016/j.ajo.2010.01.038. Epub 2010 May 5     [PubMed PMID: 20447613]

Level 1 (high-level) evidence

[49]

Didier ES, Maddry JA, Brindley PJ, Stovall ME, Didier PJ. Therapeutic strategies for human microsporidia infections. Expert review of anti-infective therapy. 2005 Jun:3(3):419-34     [PubMed PMID: 15954858]


[50]

Hooper DC, Jacoby GA. Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance. Cold Spring Harbor perspectives in medicine. 2016 Sep 1:6(9):. doi: 10.1101/cshperspect.a025320. Epub 2016 Sep 1     [PubMed PMID: 27449972]

Level 3 (low-level) evidence

[51]

Theng J, Chan C, Ling ML, Tan D. Microsporidial keratoconjunctivitis in a healthy contact lens wearer without human immunodeficiency virus infection. Ophthalmology. 2001 May:108(5):976-8     [PubMed PMID: 11320030]

Level 3 (low-level) evidence

[52]

Guruceaga X, Perez-Cuesta U, Abad-Diaz de Cerio A, Gonzalez O, Alonso RM, Hernando FL, Ramirez-Garcia A, Rementeria A. Fumagillin, a Mycotoxin of Aspergillus fumigatus: Biosynthesis, Biological Activities, Detection, and Applications. Toxins. 2019 Dec 20:12(1):. doi: 10.3390/toxins12010007. Epub 2019 Dec 20     [PubMed PMID: 31861936]


[53]

Werbovetz K. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents. Current opinion in investigational drugs (London, England : 2000). 2006 Feb:7(2):147-57     [PubMed PMID: 16499285]

Level 3 (low-level) evidence

[54]

Mohanty A, Mitra S, Mallick A, Barik MR, Das S, Priyadarshini S, Sahu SK. Sequelae of microsporidial keratoconjunctivitis and its management. Indian journal of ophthalmology. 2021 Jun:69(6):1537-1543. doi: 10.4103/ijo.IJO_1971_20. Epub     [PubMed PMID: 34011737]


[55]

Mohanty A, Sahu SK, Sharma S, Mittal R, Behera HS, Das S, Lakhmipathy M. Past, present, and prospects in microsporidial keratoconjunctivitis- A review. The ocular surface. 2023 Apr:28():364-377. doi: 10.1016/j.jtos.2021.08.008. Epub 2021 Aug 19     [PubMed PMID: 34419638]


[56]

Alkatan HM, Al-Zaaidi S, Athmanathan S. Microsporidial keratitis: Literature review and report of 2 cases in a tertiary eye care center. Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. 2012 Apr:26(2):199-203. doi: 10.1016/j.sjopt.2012.02.007. Epub 2012 Feb 16     [PubMed PMID: 23960992]

Level 3 (low-level) evidence

[57]

Natsch S, Steeghs MH, Hekster YA, Meis JF, van der Meer JW, Kullberg BJ. Use of fluconazole in daily practice: still room for improvement. The Journal of antimicrobial chemotherapy. 2001 Aug:48(2):303-10     [PubMed PMID: 11481307]


[58]

Sardana K, Kaur R, Arora P, Goyal R, Ghunawat S. Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre? Indian dermatology online journal. 2018 Mar-Apr:9(2):90-95. doi: 10.4103/idoj.IDOJ_137_17. Epub     [PubMed PMID: 29644192]


[59]

Rossi P, Urbani C, Donelli G, Pozio E. Resolution of microsporidial sinusitis and keratoconjunctivitis by itraconazole treatment. American journal of ophthalmology. 1999 Feb:127(2):210-2     [PubMed PMID: 10030568]

Level 3 (low-level) evidence

[60]

Gajdatsy AD, Tay-Kearney ML. Microsporidial keratoconjunctivitis after HAART. Clinical & experimental ophthalmology. 2001 Oct:29(5):327-9     [PubMed PMID: 11720161]

Level 3 (low-level) evidence

[61]

Das S, Wallang BS, Sharma S, Bhadange YV, Balne PK, Sahu SK. The efficacy of corneal debridement in the treatment of microsporidial keratoconjunctivitis: a prospective randomized clinical trial. American journal of ophthalmology. 2014 Jun:157(6):1151-5. doi: 10.1016/j.ajo.2014.02.050. Epub 2014 Feb 28     [PubMed PMID: 24589573]

Level 1 (high-level) evidence

[62]

Han Y, Gao H, Xu J, Luo J, Han B, Bao J, Pan G, Li T, Zhou Z. Innate and Adaptive Immune Responses Against Microsporidia Infection in Mammals. Frontiers in microbiology. 2020:11():1468. doi: 10.3389/fmicb.2020.01468. Epub 2020 Jun 26     [PubMed PMID: 32670257]


[63]

Martin R. Cornea and anterior eye assessment with slit lamp biomicroscopy, specular microscopy, confocal microscopy, and ultrasound biomicroscopy. Indian journal of ophthalmology. 2018 Feb:66(2):195-201. doi: 10.4103/ijo.IJO_649_17. Epub     [PubMed PMID: 29380757]


[64]

Toney-Butler TJ, Gasner A, Carver N. Hand Hygiene. StatPearls. 2024 Jan:():     [PubMed PMID: 29262113]


[65]

Lievens CW, Cilimberg KC, Moore A. Contact lens care tips for patients: an optometrist's perspective. Clinical optometry. 2017:9():113-121. doi: 10.2147/OPTO.S139651. Epub 2017 Aug 11     [PubMed PMID: 30214367]

Level 3 (low-level) evidence

[66]

Stellwagen A, MacGregor C, Kung R, Konstantopoulos A, Hossain P. Personal hygiene risk factors for contact lens-related microbial keratitis. BMJ open ophthalmology. 2020:5(1):e000476. doi: 10.1136/bmjophth-2020-000476. Epub 2020 Sep 8     [PubMed PMID: 32953996]